We are aiming to identify molecular mechanisms underlying inflammation and immune-modulated diseases.  Our research includes the response to infection and an understanding of the role of innate and adaptive immune systems in disease processes, including the development of drug therapies.

Principal Investigators:

  • Rasha Abu Eid (T-cell Biology, Cancer Immunology, Immune Modulators)
  • Helen Galley (sepsis, melatonin, inflammation)
  • Andy Porter (Inflammation, Biologics drug discovery, Antibody engineering)
  • Mark Vickers (Regulatory T-lymphocytes, Human Herpesvirus 4, Autoimmune Hemolytic Anemia)
  • Frank Ward (Autoantigens, Regulatory T-lymphocytes, Autoimmune Hemolytic Anemia)
  • Heather Wilson (Macrophages, Inflammatory disease and Intracellular signalling)